Renin Observed with Added Dapagliflozin - an Evaluation under Unexceptional RAS Inhibitor Administration.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2018
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ROAD-EURASIA
- 05 Jul 2016 Status changed from not yet recruiting to recruiting.
- 04 Jul 2016 Planned initiation date changed from 1 Apr 2016 to 4 Jul 2016.
- 28 May 2016 New trial record